These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2882339)

  • 1. Effectiveness of low-dose heparin in prevention of myocardial reinfarction.
    Neri Serneri GG; Rovelli F; Gensini GF; Pirelli S; Carnovali M; Fortini A
    Lancet; 1987 Apr; 1(8539):937-42. PubMed ID: 2882339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial.
    Stone GW; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Kornowski R; Hartmann F; Gersh BJ; Pocock SJ; Dangas G; Wong SC; Fahy M; Parise H; Mehran R;
    Lancet; 2011 Jun; 377(9784):2193-204. PubMed ID: 21665265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, predictors, and implications of reinfarction after primary percutaneous coronary intervention in ST-segment-elevation myocardial infarction: the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial.
    Stone SG; Serrao GW; Mehran R; Tomey MI; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Möckel M; Brener SJ; Dangas G; Stone GW
    Circ Cardiovasc Interv; 2014 Aug; 7(4):543-51. PubMed ID: 24939928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised controlled trial of subcutaneous calcium-heparin in acute myocardial infarction. The SCATI (Studio sulla Calciparina nell'Angina e nella Trombosi Ventricolare nell'Infarto) Group.
    Lancet; 1989 Jul; 2(8656):182-6. PubMed ID: 2568520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group.
    Lancet; 1996 Mar; 347(9001):561-8. PubMed ID: 8596317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial.
    Mehran R; Lansky AJ; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Kornowski R; Hartmann F; Gersh BJ; Pocock SJ; Wong SC; Nikolsky E; Gambone L; Vandertie L; Parise H; Dangas GD; Stone GW;
    Lancet; 2009 Oct; 374(9696):1149-59. PubMed ID: 19717185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials.
    Collins R; MacMahon S; Flather M; Baigent C; Remvig L; Mortensen S; Appleby P; Godwin J; Yusuf S; Peto R
    BMJ; 1996 Sep; 313(7058):652-9. PubMed ID: 8811758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial.
    Gibson RS; Boden WE; Theroux P; Strauss HD; Pratt CM; Gheorghiade M; Capone RJ; Crawford MH; Schlant RC; Kleiger RE
    N Engl J Med; 1986 Aug; 315(7):423-9. PubMed ID: 3526151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin and secondary prevention of acute myocardial infarction.
    Lotto A; Colombo A; Talarico G; Fratianni G; Lettino M
    Haemostasis; 1990; 20 Suppl 1():132-41. PubMed ID: 1982106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group.
    Lancet; 1997 May; 349(9065):1569-81. PubMed ID: 9174558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An international multicentre trial.
    Lancet; 1975 Jul; 2(7924):45-51. PubMed ID: 49649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin and warfarin therapy after acute myocardial infarction.
    Yedinak KC; Sproat TT
    Clin Pharm; 1993 Mar; 12(3):197-215. PubMed ID: 8491077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of smoking habits and timolol treatment on mortality and reinfarction in patients surviving acute myocardial infarction.
    Rønnevik PK; Gundersen T; Abrahamsen AM
    Br Heart J; 1985 Aug; 54(2):134-9. PubMed ID: 3893489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation.
    Yusuf S; Mehta SR; Xie C; Ahmed RJ; Xavier D; Pais P; Zhu J; Liu L;
    JAMA; 2005 Jan; 293(4):427-35. PubMed ID: 15671427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The efficacy and tolerance of heparin-calcium at low doses in postinfarct ischemic cardiopathy].
    Melina D; Guerrera G; Melina G; Guerrera C
    Clin Ter; 1992 Dec; 141(12):447-56. PubMed ID: 1493666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction.
    Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators
    Lancet; 2001 Aug; 358(9282):605-13. PubMed ID: 11530146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The feasibility and tolerability of prolonged treatment with low doses of heparin-calcium administered subcutaneously in infarct patients. A multicenter clinical study].
    Fernandez C; Proto C; Schiassi M; Scotti A
    Recenti Prog Med; 1993 Dec; 84(12):834-42. PubMed ID: 8108597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction.
    Turpie AG; Robinson JG; Doyle DJ; Mulji AS; Mishkel GJ; Sealey BJ; Cairns JA; Skingley L; Hirsh J; Gent M
    N Engl J Med; 1989 Feb; 320(6):352-7. PubMed ID: 2643772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials.
    Eikelboom JW; Quinlan DJ; Mehta SR; Turpie AG; Menown IB; Yusuf S
    Circulation; 2005 Dec; 112(25):3855-67. PubMed ID: 16344381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low molecular weight heparin for treatment of acute myocardial infarction (FAMI): Fragmin (dalteparin sodium) in acute myocardial infarction.
    Kakkar VV; Iyengar SS; De Lorenzo F; Hargreaves JR; Kadziola ZA;
    Indian Heart J; 2000; 52(5):533-9. PubMed ID: 11256775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.